ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 189 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $313,000 | -13.3% | 18,660 | -15.5% | 0.10% | -20.0% |
| Q1 2018 | $361,000 | +10.4% | 22,090 | -13.6% | 0.12% | +12.1% |
| Q4 2017 | $327,000 | -1.5% | 25,560 | -5.3% | 0.11% | -2.7% |
| Q3 2017 | $332,000 | -25.6% | 26,990 | -49.4% | 0.11% | -14.1% |
| Q2 2017 | $446,000 | -20.6% | 53,300 | -15.3% | 0.13% | -4.5% |
| Q1 2017 | $562,000 | – | 62,900 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|